Skip to main content
JDRS · Open access journal
Joint Diseases and
Related Surgery
Online manuscript submissionSubmit a manuscript e-ISSN 2687-4792

Original Article · Open access

Dose-dependent protective effects of punicalagin on steroid-induced osteonecrosis in a rat model

PDF Cite this article

Muhammed Uslu

Department of Orthopedics and Traumatology, University of Health Sciences, Bağcılar Training and Research Hospital, İstanbul, Türkiye

ORCID: 0000-0002-1810-2713

Ozancan Biçer

Department of Orthopedics and Traumatology, University of Health Sciences, Bağcılar Training and Research Hospital, İstanbul, Türkiye

ORCID: 0000-0002-6080-177X

Yiğit Önaloğlu

Department of Orthopedics and Traumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye

ORCID: 0000-0002-3893-797X

Emincan Balcı

Department of Orthopedics and Traumatology, University of Health Sciences, Bağcılar Training and Research Hospital, İstanbul, Türkiye

ORCID: 0000-0002-1565-9620

Yiğit Güleryüz

Department of Orthopedics and Traumatology, University of Health Sciences, Bağcılar Training and Research Hospital, İstanbul, Türkiye

ORCID: 0000-0002-9220-9578

Abdurrahman Acar

Department of Orthopedics and Traumatology, University of Health Sciences, Bağcılar Training and Research Hospital, İstanbul, Türkiye

ORCID: 0000-0003-3747-267X

Mustafa Fatih Daşcı

Department of Orthopedics and Traumatology, Medipol Mega University Hospital, İstanbul, Türkiye

ORCID: 0000-0002-2443-4802

Ender Alagöz

Department of Orthopedics and Traumatology, Medipol Mega University Hospital, İstanbul, Türkiye

ORCID: 0000-0003-0340-3879

Abstract

Objectives: This study aims to evaluate the dose-dependent protective effects of punicalagin (PUN) in a rat model of Steroidinduced osteonecrosis of the femoral head (SONFH).

Materials and methods: Twenty-four male Wistar albino rats were randomly assigned to four groups (n = 6 per group): control, osteonecrosis (ON), ON treated with 10 mg/kg PUN, and ON treated with 40 mg/kg PUN. Osteonecrosis was induced using lipopolysaccharide and methylprednisolone. Femoral heads were evaluated using micro-computed tomography (CT), histopathological examination, and immunohistochemical analysis of cleaved caspase-3. Serum oxidative stress and antioxidant parameters including malondialdehyde (MDA), reduced glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were measured.

Results: The primary outcome measure, the percentage of empty lacunae, was significantly higher in the ON group compared to controls (p = 0.01), showing a numerical reduction in the 40 mg/kg PUN group. Histopathological evaluation demonstrated a significant reduction in pyknotic cells in the high-dose PUN group compared to the ON group (p < 0.05). Furthermore, PUN treatment reduced the incidence of osteonecrosis (2/6 vs. 6/6; p < 0.01) and improved trabecular architecture. Immunohistochemical analysis showed decreased caspase-3 expression specifically in trabecular bone and adipocytes in the high-dose PUN group (p < 0.01), while downward trends were observed in bone marrow and endothelial cells. Micro-CT analysis confirmed a significant reduction in bone mineral density in the ON group compared to controls (p = 0.02). Regarding oxidative stress, although no statistically significant differences were observed, numerical trends toward reduced lipid peroxidation (p = 0.61) and a strong trend toward enhanced antioxidant capacity (GSH; p = 0.07) with a moderate-to-large effect size were noted.

Conclusion: Punicalagin may exert dose-dependent protective effects against SONFH in rats, primarily associated with reduced apoptotic activity and partial preservation of bone microarchitecture. While systemic oxidative stress markers show numerical improvements, the marked reduction in osteocyte apoptosis and necrotic incidence suggests that PUN represents a promising adjunctive strategy for mitigating steroid-related bone injury.

Declarations

Author Contributions

M.U.: Idea/concept, writing the article; O.B.: Data collection and processing; Y.Ö.: Analysis and interpretation; E.C.B.: Materials, references; Y.G.: Critical Review, data collection; A.A.: Literature review; M.F.D.: Critical review, writing the article; E.A.: Control/ supervision.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

This work was funded by Revolving Fund Budget Research and Development Expenses Account of Bagcilar Education and Research Hospital, Istanbul, Turkey (22.01.2021; No. 2021/1).

Acknowledgments

The authors would like to thank the Bagcilar Training and Research Hospital Experimental Research and Skill Development Center for providing infrastructure and technical support for the experimental procedures. The authors also gratefully acknowledge Büşra Yaprak Bayrak (Department of Pathology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye) for her valuable contributions to the pathological evaluations.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

AI Disclosure

The authors declare that artificial intelligence (AI) tools were not used, or were used solely for language editing, and had no role in data analysis, interpretation, or the formulation of conclusions. All scientific content, data interpretation, and conclusions are the sole responsibility of the authors. The authors further confirm that AI tools were not used to generate, fabricate, or ‘hallucinate’ references, and that all references have been carefully verified for accuracy.

References

  1. Atik OŞ. Corticosteroid-induced avascular necrosis of the femoral head is increased in the treatment of COVID-19 pandemic. Jt Dis Relat Surg 2023;34:757-8. DOI: 10.52312/jdrs.2023.57917.
  2. Gagala J, Buraczynska M, Mazurkiewicz T, Ksiazek A. Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland. BMC Musculoskelet Disord 2013;14:264. DOI: 10.1186/1471-2474-14-264.
  3. Konarski W, Poboży T, Kotela A, Śliwczyński A, Kotela I, Hordowicz M, et al. Does diabetes mellitus increase the risk of avascular osteonecrosis? A systematic review and metaanalysis. Int J Environ Res Public Health 2022;19:15219. DOI: 10.3390/ijerph192215219.
  4. Konarski W, Poboży T, Śliwczyński A, Kotela I, Krakowiak J, Hordowicz M, et al. Avascular necrosis of femoral headoverview and current state of the art. Int J Environ Res Public Health 2022;19:7348. DOI: 10.3390/ijerph19127348.
  5. Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev 2019;4:85-97. DOI: 10.1302/2058-5241.4.180036.
  6. Chen Y, Miao Y, Liu K, Xue F, Zhu B, Zhang C, et al. Evolutionary course of the femoral head osteonecrosis: Histopathological - radiologic characteristics and clinical staging systems. J Orthop Translat 2021;32:28-40. DOI: 10.1016/j.jot.2021.07.004.
  7. Guggenbuhl P, Robin F, Cadiou S, Albert JD. Etiology of avascular osteonecrosis of the femoral head. Morphologie 2021;105:80-4. DOI: 10.1016/j.morpho.2020.12.002.
  8. Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: A primer. Perm J 2019;23:18-100. DOI: 10.7812/TPP/18-100.
  9. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME. Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev 2010;9:721-43. DOI: 10.1016/j.autrev.2010.06.007.
  10. Wang A, Ren M, Wang J. The pathogenesis of steroidinduced osteonecrosis of the femoral head: A systematic review of the literature. Gene 2018;671:103-9. DOI: 10.1016/j.gene.2018.05.091.
  11. Krez A, Lane J, Heilbronner A, Park-Min KH, Kaneko K, Pannellini T, et al. Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis. Osteoporos Int 2021;32:2095-103. DOI: 10.1007/s00198-021-05947-x.
  12. Mont MA, Pivec R, Banerjee S, Issa K, Elmallah RK, Jones LC. High-dose corticosteroid use and risk of hip osteonecrosis: Meta-analysis and systematic literature review. J Arthroplasty 2015;30:1506-12.e5. DOI: 10.1016/j.arth.2015.03.036.
  13. Skoner DP. Inhaled corticosteroids: Effects on growth and bone health. Ann Allergy Asthma Immunol 2016;117:595- 600. DOI: 10.1016/j.anai.2016.07.043.
  14. Stowe CB. The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement Ther Clin Pract 2011;17:113-5. DOI: 10.1016/j.ctcp.2010.09.004.
  15. Tyagi S, Agarwal S, Agarwal S, Tyagi A Punicalagins - a large polyphenol compound found in pomegranates: a therapeutic review. Acad J Plant Sci 2012;5:45-9.
  16. Chen B, Longtine MS, Riley JK, Nelson DM. Antenatal pomegranate juice rescues hypoxia-induced fetal growth restriction in pregnant mice while reducing placental cell stress and apoptosis. Placenta 2018;66:1-7. DOI: 10.1016/j.placenta.2018.04.009.
  17. Fouad AA, Qutub HO, Al-Melhim WN. Punicalagin alleviates hepatotoxicity in rats challenged with cyclophosphamide. Environ Toxicol Pharmacol 2016;45:158- 62. DOI: 10.1016/j.etap.2016.05.031.
  18. Xu J, Gong H, Lu S, Deasey MJ, Cui Q. Animal models of steroid-induced osteonecrosis of the femoral head-a comprehensive research review up to 2018. Int Orthop 2018;42:1729-37. DOI: 10.1007/s00264-018-3956-1.
  19. Yaidikar L, Byna B, Thakur SR. Neuroprotective effect of punicalagin against cerebral ischemia reperfusioninduced oxidative brain injury in rats. J Stroke Cerebrovasc Dis 2014;23:2869-78. DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.020.
  20. Yaidikar L, Thakur S. Punicalagin attenuated cerebral ischemia-reperfusion insult via inhibition of proinflammatory cytokines, up-regulation of Bcl-2, down-regulation of Bax, and caspase-3. Mol Cell Biochem 2015;402:141-8. DOI: 10.1007/s11010-014-2321-y.
  21. Dong Y, Li Y, Huang C, Gao K, Weng X. Systemic application of teriparatide for steroid induced osteonecrosis in a rat model. BMC Musculoskelet Disord 2015;16:163. DOI: 10.1186/s12891-015-0589-z.
  22. Lin X, Peng Q, Zhang J, Li X, Huang J, Duan S, et al. Quercetin prevents lipopolysaccharide-induced experimental preterm labor in mice and increases offspring survival rate. Reprod Sci 2020;27:1047-57. DOI: 10.1007/s43032-019-00034-3.
  23. Dasci MF, Yaprak Sarac E, Gok Yurttas A, Atci T, Uslu M, Acar A, et al. The effects of thymoquinone on steroidinduced femoral head osteonecrosis: An experimental study in rats. Jt Dis Relat Surg 2022;33:553-66. DOI: 10.52312/jdrs.2022.752.
  24. Li H, Zhang C, Zeng B. Changes in bone micro-architecture and bone mineral density following experimental osteonecrosis of femoral head by local injection of ethanol in canines. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008;22:281-9.
  25. Huang L, Lu S, Bian M, Wang J, Yu J, Ge J, et al. Punicalagin attenuates TNF-α-induced oxidative damage and promotes osteogenic differentiation of bone mesenchymal stem cells by activating the Nrf2/HO-1 pathway. Exp Cell Res 2023;430:113717. DOI: 10.1016/j.yexcr.2023.113717.
  26. Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: A systematic literature review. Clin Ther 2017;39:2216-29. DOI: 10.1016/j.clinthera.2017.09.011.
  27. Huang C, Wen Z, Niu J, Lin S, Wang W. Steroid-induced osteonecrosis of the femoral head: Novel insight ınto the roles of bone endothelial cells in pathogenesis and treatment. Front Cell Dev Biol 2021;9:777697. DOI: 10.3389/fcell.2021.777697.
  28. Ding M, Wang Y, Sun D, Liu Z, Wang J, Li X, et al. Punicalagin pretreatment attenuates myocardial ischemiareperfusion injury via activation of AMPK. Am J Chin Med 2017;45:53-66. DOI: 10.1142/S0192415X17500057.
  29. Foroutanfar A, Mehri S, Kamyar M, Tandisehpanah Z, Hosseinzadeh H. Protective effect of punicalagin, the main polyphenol compound of pomegranate, against acrylamideinduced neurotoxicity and hepatotoxicity in rats. Phytother Res 2020;34:3262-72. DOI: 10.1002/ptr.6774.
  30. Fouad AA, Qutub HO, Al-Melhim WN. Nephroprotection of punicalagin in rat model of endotoxemic acute kidney injury. Toxicol Mech Methods 2016;26:538-43. DOI: 10.1080/15376516.2016.1211207.
  31. Zhao ZQ, Bai R, Liu WL, Feng W, Zhao AQ, Wang Y, et al. Roles of oxidative DNA damage of bone marrow hematopoietic cells in steroid-induced avascular necrosis of femoral head. Genet Mol Res 2016;15. DOI: 10.4238/gmr.15017706.
  32. Erturk C, Diril SK, Yuzbasioglu Ozturk G, Gulcubuk A, Oran DS, Erdogan Bamac O, et al. Extra virgin olive oil alleviates articular cartilage damage and reduces ox-LDL and oxidative stress in monosodium iodoacetate-induced osteoarthritis in rats. Clin Rheumatol 2025;44:4353-65. DOI: 10.1007/s10067-025-07621-7.
  33. Wang Q, Ge G , Liang X, Bai J, Wang W, Zhang W, et al. Punicalagin ameliorates wear-particle-induced inflammatory bone destruction by bi-directional regulation of osteoblastic formation and osteoclastic resorption. Biomater Sci 2020;8:5157-71. DOI: 10.1039/d0bm00718h.
  34. Li T, Jiang G, Hu X, Yang D, Tan T, Gao Z, et al. Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts. Front Pharmacol 2021;12:789552. DOI: 10.3389/fphar.2021.789552.